摘要
目的探讨替罗非班联合丁苯酞应用于进展性脑梗死的疗效与安全性。方法选取2016年1月—2018年1月广州医科大学附属第三医院神经内科收治的进展性脑梗死患者98例。对照组采用硫酸氢氯吡格雷加阿司匹林(双抗)治疗,观察组采用替罗非班(静脉治疗48 h)联合丁苯酞序贯双抗治疗。结果替罗非班联合丁苯酞序贯双抗治疗组的神经功能缺损(NIHSS)评分、日常生活能力评定量表(Barthel指数)、改良Rankin量表评分优于对照组,血浆凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)与凝血酶时间(TT)水平高于对照组,两组有差异。两组患者药物不良反应发生率无差异。结论替罗非班联合丁苯酞序贯双抗治疗可明显改善进展性脑梗死的神经功能,为时间窗外的进展性脑梗死提供了治疗方法,疗效显著。
Objective To observe the effect and safety of triofiban combined with butylphthalide in treatment of progressive cerebral infarction.Methods A total of 98 patients with progressive cerebral infarction in the department of neurology from January 2016 to January 2018.The control group was treated with clopidogrel hydrogen sulfate plus aspirin(dual antiplatelet).The observer group was treated with Tirofiban(48 h intravenous treatment)combined with butylphthalide on the basis of the treatment of the control group.Results The score of National Institutes of Health Stroke、Barthel Index and mRS in the triofiban combined with butylphthalide group were better than that of the control group.There were statistical differences between the two groups.PT,APTT and TT were higher than that in the control group.There was no significant dif.ference in drug adverse reactions between the two groups.Conclusion Triofiban combined with butylphthalide may improve the neurologic function of progressive cerebral infarction and provide treatment for progressive cerebral infarction outside the time window.
作者
许璇
余科
曾洁芳
韦朝霞
XU Xuan;YU Ke;ZENG Jiefang;WEI Zhaoxia(The Liwan Hospital of The Third Affiliated Hospital of Guangzhou Medical University Guangzhou 510000,China)
出处
《广州医药》
2019年第1期76-79,共4页
Guangzhou Medical Journal
基金
广州市荔湾区科技计划项目(20151217090)
关键词
替罗非班
丁苯酞
进展性脑梗死
Triofiban
Butylphthalide
Progressive cerebral infarction
